Biocartis Group NV
XBRU:BCART

Watchlist Manager

Biocartis Group NV

XBRU:BCART

Watchlist

Dividends

Price: 0.29 EUR Market Closed

Market Cap: 27.2m EUR

Have any thoughts about
Biocartis Group NV?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 0.29 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BCART Alert

Biocartis Group NV

0.29

0.00 (0%)

52 Week Range	0.29 0.29
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Biocartis Group NV

What unique competitive advantages
does Biocartis Group NV hold over its rivals?

What risks and challenges
does Biocartis Group NV face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Biocartis Group NV.

What unique competitive advantages
does Biocartis Group NV hold over its rivals?

What risks and challenges
does Biocartis Group NV face in the near future?

Has there been any significant insider trading activity
in Biocartis Group NV recently?

Summarize the latest earnings call
of Biocartis Group NV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biocartis Group NV.

Provide P/S
for Biocartis Group NV.

Provide P/E
for Biocartis Group NV.

Provide P/OCF
for Biocartis Group NV.

Provide P/FCFE
for Biocartis Group NV.

Provide P/B
for Biocartis Group NV.

Provide EV/S
for Biocartis Group NV.

Provide EV/GP
for Biocartis Group NV.

Provide EV/EBITDA
for Biocartis Group NV.

Provide EV/EBIT
for Biocartis Group NV.

Provide EV/OCF
for Biocartis Group NV.

Provide EV/FCFF
for Biocartis Group NV.

Provide EV/IC
for Biocartis Group NV.

What are the Revenue projections
for Biocartis Group NV?

How accurate were the past Revenue estimates
for Biocartis Group NV?

What are the Net Income projections
for Biocartis Group NV?

How accurate were the past Net Income estimates
for Biocartis Group NV?

What are the EPS projections
for Biocartis Group NV?

How accurate were the past EPS estimates
for Biocartis Group NV?

What are the EBIT projections
for Biocartis Group NV?

How accurate were the past EBIT estimates
for Biocartis Group NV?

Compare the revenue forecasts
for Biocartis Group NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biocartis Group NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biocartis Group NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biocartis Group NV compared to its peers.

Compare the P/E ratios
of Biocartis Group NV against its peers.

Discuss the investment returns and shareholder value creation
comparing Biocartis Group NV with its peers.

Analyze the financial leverage
of Biocartis Group NV compared to its main competitors.

Show all profitability ratios
for Biocartis Group NV.

Provide ROE
for Biocartis Group NV.

Provide ROA
for Biocartis Group NV.

Provide ROIC
for Biocartis Group NV.

Provide ROCE
for Biocartis Group NV.

Provide Gross Margin
for Biocartis Group NV.

Provide Operating Margin
for Biocartis Group NV.

Provide Net Margin
for Biocartis Group NV.

Provide FCF Margin
for Biocartis Group NV.

Show all solvency ratios
for Biocartis Group NV.

Provide D/E Ratio
for Biocartis Group NV.

Provide D/A Ratio
for Biocartis Group NV.

Provide Interest Coverage Ratio
for Biocartis Group NV.

Provide Altman Z-Score Ratio
for Biocartis Group NV.

Provide Quick Ratio
for Biocartis Group NV.

Provide Current Ratio
for Biocartis Group NV.

Provide Cash Ratio
for Biocartis Group NV.

What is the historical Revenue growth
over the last 5 years for Biocartis Group NV?

What is the historical Net Income growth
over the last 5 years for Biocartis Group NV?

What is the current Free Cash Flow
of Biocartis Group NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biocartis Group NV.

BCART

Cash Flow Statement

Cash from Financing Activities

Biocartis Group NV
Cash from Financing Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Biocartis Group NV
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

	Cash from Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Biocartis Group NV XBRU:BCART	Cash from Financing Activities €61.7m	CAGR 3-Years N/A	CAGR 5-Years -4%	CAGR 10-Years N/A
Nyxoah SA XBRU:NYXH	Cash from Financing Activities €16.9m	CAGR 3-Years -45%	CAGR 5-Years 2%	CAGR 10-Years N/A
Ion Beam Applications SA XBRU:IBAB	Cash from Financing Activities -€14.4m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Sequana Medical NV XBRU:SEQUA	Cash from Financing Activities €12.7m	CAGR 3-Years -22%	CAGR 5-Years -16%	CAGR 10-Years N/A

No Stocks Found

Biocartis Group NV
Glance View

Market Cap

27m EUR

Industry

Health Care

Biocartis Group NV which engages in the development of oncology molecular diagnostic solutions. The company is headquartered in Malines (Mechelen), Antwerpen and currently employs 619 full-time employees. The company went IPO on 2015-04-27. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.

Open BCART Analysis

BCART Intrinsic Value

0.94 EUR

Undervaluation 69%

Intrinsic Value

Price

What is Intrinsic Value?

What is Biocartis Group NV's Cash from Financing Activities?

Cash from Financing Activities
61.7m EUR

Based on the financial report for Jun 30, 2023, Biocartis Group NV's Cash from Financing Activities amounts to 61.7m EUR.

Biocartis Group NV
XBRU:BCART

Biocartis Group NV
Cash from Financing Activities

Biocartis Group NV
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Biocartis Group NV
Glance View

See Also

What is Biocartis Group NV's Cash from Financing Activities?

Cash from Financing Activities
61.7m EUR

What is Biocartis Group NV's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 5Y
-4%

Company

Help

Tools

Stocks

Biocartis Group NV XBRU:BCART

Biocartis Group NV Cash from Financing Activities

Biocartis Group NV Cash from Financing Activities Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

Biocartis Group NV Glance View

See Also

What is Biocartis Group NV's Cash from Financing Activities? Cash from Financing Activities 61.7m EUR

What is Biocartis Group NV's Cash from Financing Activities growth rate? Cash from Financing Activities CAGR 5Y -4%

Company

Help

Tools

Stocks

Biocartis Group NV
XBRU:BCART

Biocartis Group NV
Cash from Financing Activities

Biocartis Group NV
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Biocartis Group NV
Glance View

What is Biocartis Group NV's Cash from Financing Activities?

Cash from Financing Activities
61.7m EUR

What is Biocartis Group NV's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 5Y
-4%